arrow5 Comments
  1. [...] Alice kindly petitions for cert, please grant it – we just can’t figure out how to apply Bilski v. Kappos when it comes to computer system claims (and some of us are also unhappy when it comes to the [...]

  2. [...] Bilski: S.Ct Refuses to Prohibit Software, Business Method, and Medical Diagnostic Method Patents [...]

  3. [...] In the never-ending battle for truth, justice and invalidating methods on natural phenomenon the U.S. Court of Appeals for the Federal Circuit has once again taken up the burden to review the case of Classen Immunotherapies, Inc. v. Biogen IDEC (06-1634, -1649), after the Supreme Court vacated the CAFC’s earlier decision in view of the Court’s decision in Bilski v. Kappos. [...]

  4. Gena777
    Jul 06 - 11:56 am

    The Supremes’ opinion was maddeningly, if perhaps necessarily, short on specifics, definitions, or the means of determining patentability. More than anything else, it seems to represent a maintaining of the status quo in patent law. The main difference is that, instead of stewing over machines and transformations, we’ll all be trying to figure out what exactly is an abstract idea. Meet the new boss, same as the old boss.

  5. [...] This post was mentioned on Twitter by FreshPatents – Chris. FreshPatents – Chris said: Bilski: S.Ct Refuses to Prohibit Software, Business Method: [...]

Mobile Theme